Accelerate Diagnostics, Inc. (AXDX)
USD 0.64
(-7.51%)
USD 0.64
(-7.51%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 36.1 Million USD | 88.18% |
| 2022 | 19.18 Million USD | -82.62% |
| 2021 | 110.36 Million USD | -25.9% |
| 2020 | 148.93 Million USD | 11.46% |
| 2019 | 133.62 Million USD | 11.28% |
| 2018 | 120.07 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | -100.0% |
| 2014 | 13 Thousand USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 41.06 Million USD | 9.05% |
| 2024 Q1 | 37.65 Million USD | 4.3% |
| 2023 FY | 36.1 Million USD | 88.18% |
| 2023 Q1 | 19.44 Million USD | 1.34% |
| 2023 Q2 | 33.72 Million USD | 73.47% |
| 2023 Q4 | 36.1 Million USD | 4.91% |
| 2023 Q3 | 34.41 Million USD | 2.03% |
| 2022 Q1 | 118.11 Million USD | 7.02% |
| 2022 FY | 19.18 Million USD | -82.62% |
| 2022 Q4 | 19.18 Million USD | -74.45% |
| 2022 Q3 | 75.09 Million USD | -31.23% |
| 2022 Q2 | 109.2 Million USD | -7.54% |
| 2021 Q3 | 112.71 Million USD | -26.73% |
| 2021 Q4 | 110.36 Million USD | -2.09% |
| 2021 FY | 110.36 Million USD | -25.9% |
| 2021 Q1 | 151.21 Million USD | 1.53% |
| 2021 Q2 | 153.84 Million USD | 1.74% |
| 2020 Q3 | 146.55 Million USD | 3.58% |
| 2020 Q4 | 148.93 Million USD | 1.62% |
| 2020 Q1 | 136.18 Million USD | 1.92% |
| 2020 FY | 148.93 Million USD | 11.46% |
| 2020 Q2 | 141.49 Million USD | 3.9% |
| 2019 Q2 | 125.09 Million USD | 1.95% |
| 2019 Q3 | 130.9 Million USD | 4.64% |
| 2019 FY | 133.62 Million USD | 11.28% |
| 2019 Q4 | 133.62 Million USD | 2.08% |
| 2019 Q1 | 122.7 Million USD | 2.19% |
| 2018 Q1 | 99.16 Million USD | 0.0% |
| 2018 FY | 120.07 Million USD | 0.0% |
| 2018 Q4 | 120.07 Million USD | 1.97% |
| 2018 Q3 | 117.75 Million USD | 1.95% |
| 2018 Q2 | 115.49 Million USD | 16.48% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | -100.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | 13 Thousand USD | 0.0% |
| 2014 Q1 | 124 Thousand USD | 0.0% |
| 2014 Q3 | 50 Thousand USD | -42.53% |
| 2014 Q4 | 13 Thousand USD | -74.0% |
| 2014 Q2 | 87 Thousand USD | -29.84% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| BrainsWay Ltd. | 239 Thousand USD | -15005.439% |
| Cerus Corporation | 59.79 Million USD | 39.625% |
| Envoy Medical, Inc. | 404 Thousand USD | -8836.139% |
| electroCore, Inc. | 537 Thousand USD | -6622.905% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -300750.0% |
| IceCure Medical Ltd | 376 Thousand USD | -9501.596% |
| Inogen, Inc. | 18.27 Million USD | -97.603% |
| OrthoPediatrics Corp. | 13.45 Million USD | -168.237% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -18041.709% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -9825.658% |
| MaxCyte, Inc. | 17.96 Million USD | -100.913% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -65202.8% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 61.225% |
| PAVmed Inc | 2.96 Million USD | -1119.662% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -480.978% |
| RxSight, Inc. | 1.21 Million USD | -2881.173% |
| Sight Sciences, Inc. | 31.7 Million USD | -13.858% |
| SI-BONE, Inc. | 36.06 Million USD | -0.103% |
| TELA Bio, Inc. | 40.51 Million USD | 10.892% |
| Treace Medical Concepts, Inc. | 53 Million USD | 31.893% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -2273.57% |
| Acutus Medical, Inc. | 32.65 Million USD | -10.559% |
| Talis Biomedical Corporation | 16.78 Million USD | -115.072% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -792.509% |
| CVRx, Inc. | 30.38 Million USD | -18.827% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -3450.097% |
| Bioventus Inc. | 366.99 Million USD | 90.163% |
| Venus Concept Inc. | 70.79 Million USD | 49.001% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -2802.09% |
| LivaNova PLC | 568.54 Million USD | 93.65% |
| 908 Devices Inc. | 3.92 Million USD | -818.86% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 92.936% |
| Nemaura Medical Inc. | 3.08 Million USD | -1069.238% |
| NeuroPace, Inc. | 56.95 Million USD | 36.612% |
| LENSAR, Inc. | 1.75 Million USD | -1962.971% |
| Apyx Medical Corporation | 33.18 Million USD | -8.79% |
| Cutera, Inc. | 418.69 Million USD | 91.377% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -139.976% |
| BioSig Technologies, Inc. | 103 Thousand USD | -34950.485% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -34.188% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -262.871% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 97.569% |
| Axonics, Inc. | 25.84 Million USD | -39.714% |
| Outset Medical, Inc. | 134.59 Million USD | 73.177% |
| IRIDEX Corporation | 1.75 Million USD | -1961.793% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 29.679% |
| IRadimed Corporation | 1.61 Million USD | -2135.307% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -20412.5% |
| INVO Bioscience, Inc. | 6.77 Million USD | -432.785% |
| Telesis Bio, Inc. | 5.26 Million USD | -585.177% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -504.593% |
| Varex Imaging Corporation | 464.2 Million USD | 92.223% |
| Quipt Home Medical Corp. | 60.82 Million USD | 40.642% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -6039.796% |
| Pulmonx Corporation | 35.08 Million USD | -2.887% |
| Dynatronics Corporation | 3.25 Million USD | -1007.941% |
| Modular Medical, Inc. | 817 Thousand USD | -4318.849% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -23808.609% |
| Semler Scientific, Inc. | 70 Thousand USD | -51474.286% |
| InMode Ltd. | 6.61 Million USD | -445.925% |
| Bruker Corporation | 1.14 Billion USD | 96.846% |
| Cytosorbents Corporation | 2.54 Million USD | -1319.742% |
| DexCom, Inc. | 2.57 Billion USD | 98.597% |
| Align Technology, Inc. | 96.96 Million USD | 62.769% |
| Viveve Medical, Inc. | 5.12 Million USD | -604.567% |
| ZimVie Inc. | 508.79 Million USD | 92.904% |
| Movano Inc. | 15.00 USD | -240679900.0% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -99.183% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 90.943% |
| Profound Medical Corp. | 4.97 Million USD | -625.753% |
| Insulet Corporation | 1.36 Billion USD | 97.358% |
| enVVeno Medical Corporation | 1.06 Million USD | -3293.045% |
| Surmodics, Inc. | 29.4 Million USD | -22.775% |
| iCAD, Inc. | 273 Thousand USD | -13124.176% |
| Nuwellis, Inc. | 221 Thousand USD | -16235.747% |
| Biotricity, Inc. | 10.85 Million USD | -232.559% |
| iRhythm Technologies, Inc. | 34.95 Million USD | -3.296% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -5456.282% |
| InspireMD, Inc. | 1.03 Million USD | -3378.035% |
| PAVmed Inc. | 2.96 Million USD | -1119.662% |
| BIOLASE, Inc. | 13.98 Million USD | -158.148% |
| Beyond Air, Inc. | 14.72 Million USD | -145.241% |
| FONAR Corporation | 37.92 Million USD | 4.818% |
| AxoGen, Inc. | 46.6 Million USD | 22.533% |
| Vivani Medical, Inc. | 19.31 Million USD | -86.931% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 19.076% |
| Inari Medical, Inc. | 30.35 Million USD | -18.933% |
| UFP Technologies, Inc. | 28 Million USD | -28.936% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -8217.571% |
| Tenon Medical, Inc. | 428 Thousand USD | -8335.047% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -3502.994% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -1577.462% |
| AdaptHealth Corp. | 2.09 Billion USD | 98.276% |
| Sintx Technologies, Inc. | 3.68 Million USD | -879.17% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 3.012% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -6039.796% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -5957.383% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 95.954% |
| TransMedics Group, Inc. | 506.2 Million USD | 92.868% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -5847.611% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -38935.519% |
| Hyperfine, Inc. | 64 Thousand USD | -56309.375% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 80.872% |
| Biomerica, Inc. | 459 Thousand USD | -7765.359% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -7931.894% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -18902.353% |
| Silk Road Medical, Inc | 75.62 Million USD | 52.262% |